Background: The recessive X-linked disorder hemophilia A (HA) is rarely expressed in female carriers, most of whom express about half of normal factor VIII activity (
Fviii: C).
Objective: To propose an integrative assessment model for the binary role of the phase between the mutated F8 and the active X-chromosome (Xa) in
Fviii: C in HA carriers.
Methods: We studied 67 females at risk of severe HA, comprising five symptomatic females (
Fviii: C < 1.5 IU dL(-1) ) and 14 controls. A correlation study between
Fviii: C (observed vs. expected) and X-chromosome inactivation (XCI) patterns (XIPs; androgen receptor gene [AR] system) in blood leukocyte DNA was performed in carriers, by comparison of a model correlating
Fviii: C and XIP with arbitrary models devoid of biological significance, and with
Fviii: C levels in non-carriers (mean model) as a proxy from background data dispersion not influenced by XIP.
Results: We provide proof-of-concept example from a family presenting with extremely skewed XIPs in which the severe HA phenotype appeared in a heterozygous carrier of a crossover between AR and F8 loci that phased the mutated F8 with the maternally inherited Xa. Furthermore, four cases of severe HA affected women who had a combination of a heterozygous F8 mutation and extremely skewed XIPs in leukocytes or oral mucosa are presented. Correlation analyses between
Fviii: C levels and XIPs in carriers (n = 38) but not in non-carriers (n = 20) showed highly significant differences between the proposed correlation model and models without biological significance. The data support a binary influence of XCI, either increasing or decreasing the
Fviii: C, subject to the underlying phase set between the F8 mutation and XCI.
Conclusions: Our evidence suggests that the phase between XCI and mutated F8 acts as a molecular switch conditioning
Fviii: C levels and HA expression in carriers.
Keywords: F8 protein, human; X chromosome; X chromosome inactivation; X-linked genetic diseases; hemophilia A.
© 2015 International Society on Thrombosis and Haemostasis.